Brain diagnostics innovator BrainScope announced today a new investment from the Alzheimer’s Drug Discovery Foundation (ADDF) in BrainScope’s current Series B equity financing round. This investment supports the ongoing development of a new Artificial Intelligence / Machine Learning derived brain-activity based biomarker…
Stryker (NYSE: SYK), one of the world’s leading medical technology companies, announced the launch of PROstep® MIS Lapidus, a new internal fixation system intended for treating bunions using a minimally invasive surgical reduction of hallux valgus deformity and subsequent fusion of…
ChoiceSpine LLC, a privately held spinal device company held by Altus Capital Partners in Knoxville, TN, is pleased to announce today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market the Blackhawk® Ti 3D Printed…
Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared highlights from…
PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President and CEO: Patrick C. Reid, hereinafter “PeptiDream”) (Tokyo: 4587) today announced a new multi-target collaboration and license agreement with U.S.-based Genentech, a member of the Roche Group, focused on the discovery…
ChromaTanTM announced today that Dr. Rajiv Datar has been appointed the new President & CEO of the company. A bioentrepreneur with over 25 years C-level experience in bioprocessing and drug development, Dr. Datar succeeds Oleg Shinkazh, the Founder of ChromaTan, who…
Centene Foundation, the philanthropic arm of Centene Corporation (NYSE: CNC) focused on investing in initiatives with holistic approaches to dismantling barriers to health, and The Little Bit Foundation (“Little Bit”), an organization that works to eliminate barriers to learning for under-resourced students in the St. Louis region, today announced…
Cardinal Health (NYSE: CAH) in partnership with Children’s Hospitals Association (CHA) and the Zero Suicide Institute (ZSI) announced today the second round of grant recipients for the Preventing Youth Suicide: A Cardinal Health Foundation National Collaborative. The grants, which total…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending approval of KEYTRUDA, Merck’s anti-PD-1 therapy, for…
AbbVie today announced the start of its two-week public voting period for the 2023 Thriving Undergraduate and Graduate Scholarships. Following this voting period, scholarships totaling $25,000 each will be awarded to two commendable students living with cystic fibrosis (CF), an inherited chronic…
At an Extraordinary General Meeting held today, Novartis shareholders approved the proposed 100% Spin-off of Sandoz, the Generics and Biosimilars business of Novartis. Shareholders also approved an ordinary capital decrease of the share capital of Novartis AG in the amount…
Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), and North American Recue, a Henry Schein Medical business, today announced their presence at the EMS World Expo. From September 18 through September 22 in New Orleans,…